Product information and disease descriptionPlace of product in therapyDisease description
Pathophysiology
12 evidence topics · 8 sources
Bradykinin generation: activation of prekallikrein to plasma kallikrein
“In HAE-C1-INH, bradykinin is the primary mediator of swelling.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This molecule arises from cleavage of high-molecular-weight kininogen by plasma kallikrein, which is activated from prekallikrein by factor XII.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The resulting bradykinin nonapeptide increases vascular permeability and induces swelling (angioedema) through a specific receptor, B2” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Role of C1 inhibitor in regulating the kallikrein-kinin system
“C1-INH is a serine protease inhibitor protein synthesized in hepatocytes that is crucial in regulating the plasma kallikrein–kinin system (KKS) and preventing excessive bradykinin production.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“HAE-C1-INH is caused by mutations in SERPING1, which encodes C1-INH, leading to reduced levels or impaired activity of C1-INH.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This deficiency in turn leads to uncontrolled activation of the KKS and excessive bradykinin production, with bradykinin acting as the key mediator of the condition.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Bradykinin and vascular permeability
Evidence for bradykinin as the mediator of attacks: plasma levels and the B2 receptor knockout model
“In 1983, a pivotal study by Fields et al. implicated bradykinin as the likely primary mediator responsible for angioedema attacks.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This hypothesis was further supported in 1999 by Nussberger et al, who analyzed plasma samples from individuals with HAE and reported elevated bradykinin levels in blood drawn from edematous sites compared to unaffected areas.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Shortly thereafter, in 2002, a landmark experimental study using a double-knockout murine model deficient in both C1 inhibitor (C1-INH) and bradykinin B2 receptor (Bk2R) further confirmed the critical role of C1-INH deficiency and bradykinin in the pathogenesis of HAE.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Kinin receptors: bradykinin B1 and B2 receptors
“Bradykinin (BK)-related peptides, the kinins, are released from kininogens by kallikreins and exert various physiological and pathological effects via 2 related G protein-coupled receptors (GPCRs) termed the bradykinin B1 and B2 receptors” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“While kinins and their receptors mediate compensatory and protective vasodilator effects under various pathological conditions, they are also mediators of inflammation, producing plasma extravasation and edema and pain” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Bradykinin B2 receptor as the mediator of vascular permeability and swelling
“which leads to the overproduction of bradykinin and activation of bradykinin B2 receptors.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This increases vascular permeability and results in angioedema attacks.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Bradykinin is rapidly metabolized by endogenous metalloproteases including angiotensin-converting enzyme (ACE).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Increased vascular permeability and swelling induced by bradykinin are primarily mediated through the bradykinin B2 receptor.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Bradykinin binds to and stimulates the bradykinin B2 receptor, thereby mediating vasodilatation and increased capillary permeability.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Endothelial B2 receptor signaling: adherens junction disruption and resealing
Bradykinin production pathways and blockade at the receptor
Kallikrein-kinin system targets of oral treatments
“Currently approved and investigational oral treatments for HAE target components of the kallikrein‐kinin system, including plasma kallikrein (PKa), activated factor XII (FXIIa), or bradykinin B2 receptor (B2R; Figure 1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“PKa inhibitors (e.g., berotralstat, sebetralstat, ATN249, VE‐4666, and VE‐4062) and FXIIa inhibitors prevent bradykinin generation by preventing cleavage of high molecular weight kininogen, whereas B2R antagonists (e.g., deucrictibant) block bradykinin binding.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Mediators of swelling in HAE with normal C1-INH
“Current evidence indicates that excessive bradykinin generation is still involved in most cases (HAE-FXII, HAE-PLG, HAE-KNG, HAE-HSST, and HAE-CPN).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, other mediators such as VEGF and angiopoietin have emerged as candidate contributors, potentially increasing vascular permeability either directly (HAE-MYOF, HAE-DAB2IP) or indirectly (HAE-ANGPT).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote